211 related articles for article (PubMed ID: 31192763)
1. Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents.
Farhat N; Fortin Y; Haddad N; Birkett N; Mattison DR; Momoli F; Wu Wen S; Krewski D
Crit Rev Toxicol; 2019 Mar; 49(3):215-261. PubMed ID: 31192763
[TBL] [Abstract][Full Text] [Related]
2. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 - 2016).
Bundhun PK; Teeluck AR; Bhurtu A; Huang WQ
BMC Cardiovasc Disord; 2017 Jan; 17(1):3. PubMed ID: 28056809
[TBL] [Abstract][Full Text] [Related]
3. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
Kwok CS; Jeevanantham V; Dawn B; Loke YK
Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
[TBL] [Abstract][Full Text] [Related]
4. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
[TBL] [Abstract][Full Text] [Related]
5. Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.
Siller-Matula JM; Jilma B; Schrör K; Christ G; Huber K
J Thromb Haemost; 2010 Dec; 8(12):2624-41. PubMed ID: 20831618
[TBL] [Abstract][Full Text] [Related]
6. Risk of major adverse cardiovascular events for concomitant use of clopidogrel and proton pump inhibitors in patients inheriting CYP2C19 loss-of-function alleles: meta-analysis.
Biswas M; Rahaman S; Biswas TK; Ibrahim B
Int J Clin Pharm; 2021 Oct; 43(5):1360-1369. PubMed ID: 33774763
[TBL] [Abstract][Full Text] [Related]
7. Adverse cardiovascular effects of concomitant use of proton pump inhibitors and clopidogrel in patients with coronary artery disease: a systematic review and meta-analysis.
Huang B; Huang Y; Li Y; Yao H; Jing X; Huang H; Li J
Arch Med Res; 2012 Apr; 43(3):212-24. PubMed ID: 22564422
[TBL] [Abstract][Full Text] [Related]
8. Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention.
Lee D; Kim JS; Kim BJ; Shin SY; Kim DB; Ahn HS
Medicine (Baltimore); 2021 Dec; 100(52):e27411. PubMed ID: 34967346
[TBL] [Abstract][Full Text] [Related]
9. Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel.
Batchelor R; Kumar R; Gilmartin-Thomas JFM; Hopper I; Kemp W; Liew D
Aliment Pharmacol Ther; 2018 Oct; 48(8):780-796. PubMed ID: 30178881
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between the combined use of various proton pump inhibitors with antiplatelet drugs and the risk of cardiovascular complications].
Ostroumova OD; Kochetkov AI; Pereverzev AP; Kravchenko EV; Kazjulin AN; Andreev DN; Pavleeva EE
Ter Arkh; 2019 Aug; 91(8):118-126. PubMed ID: 32598763
[TBL] [Abstract][Full Text] [Related]
11. Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes.
Mandurino-Mirizzi A; Leonardi S; Melloni C
Minerva Endocrinol; 2017 Sep; 42(3):228-237. PubMed ID: 27808485
[TBL] [Abstract][Full Text] [Related]
12. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study.
Charlot M; Ahlehoff O; Norgaard ML; Jørgensen CH; Sørensen R; Abildstrøm SZ; Hansen PR; Madsen JK; Køber L; Torp-Pedersen C; Gislason G
Ann Intern Med; 2010 Sep; 153(6):378-86. PubMed ID: 20855802
[TBL] [Abstract][Full Text] [Related]
13. Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other Drugs.
Shamliyan TA; Middleton M; Borst C
Clin Ther; 2017 Feb; 39(2):404-427.e36. PubMed ID: 28189362
[TBL] [Abstract][Full Text] [Related]
14. Review of recent evidence: potential interaction between clopidogrel and proton pump inhibitors.
Last EJ; Sheehan AH
Am J Health Syst Pharm; 2009 Dec; 66(23):2117-22. PubMed ID: 19923312
[TBL] [Abstract][Full Text] [Related]
15. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M; Tafreshi J; Pai RG
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
[TBL] [Abstract][Full Text] [Related]
16. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009
[TBL] [Abstract][Full Text] [Related]
17. Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review.
Kwok CS; Loke YK
Drug Saf; 2012 Feb; 35(2):127-39. PubMed ID: 22204719
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel.
Chen M; Wei JF; Xu YN; Liu XJ; Huang DJ
Cardiovasc Ther; 2012 Oct; 30(5):e227-33. PubMed ID: 21884023
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
[TBL] [Abstract][Full Text] [Related]
20. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
